Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urocanic acid is a naturally occurring organic compound found predominantly in the upper layers of mammalian skin. It is produced from L-histidine by the enzyme histidine ammonia lyase during histidine metabolism. Urocanic acid exists mainly as the trans isomer under physiological conditions but can be converted to its cis form upon exposure to ultraviolet radiation (UVR)[7]. In the stratum corneum of human skin, it acts as a major endogenous absorber of UVB light and contributes to photoprotection against DNA damage[1][7]. The cis isomer has immunomodulatory properties and has been linked with cutaneous diseases such as atopic dermatitis and urticaria; it also associates with systemic diseases including multiple sclerosis[3]. Urocanic acid does not function as a classical therapeutic target like an enzyme or receptor but rather serves important roles in physiology and disease biomarker research. Deficiency or dysregulation can be associated with metabolic disorders such as urocanic aciduria due to inherited defects in downstream enzymes like urocanase[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urocanic acid.